Anika Therapeutics (ANIK) Change in Cash (2010 - 2026)
Anika Therapeutics (ANIK) reported Change in Cash of -$16.5 million for Q1 2026, down 334.56% year-over-year from $7.0 million in Q1 2025, and down 3133.99% quarter-over-quarter from -$509000.0 in Q4 2025.
Anika Therapeutics (ANIK) Change in Cash (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Change in Cash data on file, last reported at -$16.5 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$16.5 million, down 334.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.4 million (up 19.05% YoY), and the FY2025 annual result was $322000.0, up 102.05% from the prior year.
- Change in Cash eased to -$16.5 million in Q1 2026 per ANIK's latest filing, from -$509000.0 in the prior quarter.
- Over five years, Change in Cash peaked at $5.6 million in Q3 2023 and troughed at -$16.5 million in Q1 2026.
- A 5-year average of -$3.1 million and a median of -$3.6 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2025: Change in Cash plunged 1474.51% in 2023, then surged 1162.33% in 2025.
- A 5-year view of Change in Cash shows it stood at -$1.4 million in 2022, then soared by 252.83% to $2.2 million in 2023, then sank by 335.06% to -$5.2 million in 2024, then jumped by 90.23% to -$509000.0 in 2025, then sank by 3133.99% to -$16.5 million in 2026.
- Business Quant data shows ANIK's Change in Cash at -$16.5 million in Q1 2026, -$509000.0 in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 185.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -509.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -446.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -117.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -768.23 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 139.47 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 32.11 Mn |
| 10 | Anika Therapeutics | 198.70 Mn | 131.91 Mn | 19.00 Mn | -16.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.46 Mn |
| Dec 31, 2025 | -509,000.00 |
| Sep 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | -204,000.00 |
| Mar 31, 2025 | -3.79 Mn |
| Dec 31, 2024 | -5.21 Mn |
| Sep 30, 2024 | -454,000.00 |
| Jun 30, 2024 | -5.81 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | -14.67 Mn |
| Mar 31, 2023 | -6.59 Mn |
| Dec 31, 2022 | -1.45 Mn |
| Sep 30, 2022 | -3.62 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | -4.06 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | -6.21 Mn |
| Jun 30, 2021 | 2.58 Mn |